🇺🇸 FDA
Pipeline program

OPRX-106

PB-106-001

Phase 1 small_molecule completed

Quick answer

OPRX-106 for Human Volunteer is a Phase 1 program (small_molecule) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Protalix BioTherapeutics
Indication
Human Volunteer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials